VVigilance Weekly공개 리포트 보기
← 이번 주 리포트
tirzepatide우선순위 낮음근거 검토기타

LITERATURE DETAIL · PMID 42309121

1-year outcomes of semaglutide, tirzepatide, and sleeve gastrectomy in obesity in type 2 diabetes: a retrospective cohort study.

1-year outcomes of semaglutide, tirzepatide, and sleeve gastrectomy in obesity in type 2 diabetes: a retrospective cohort study.

저자
Daniel B Leslie, Brian T Steffen, Eric Wise, Lyn M Steffen, Kristi Kopacz, Darin Ruanpeng
저널
The lancet. Diabetes & endocrinology
공개일
2026 Aug
연구 유형
기타
DOI
10.1016/S2213-8587(26)00030-6

문헌 요약

Type 2 diabetes and obesity are prevalent, inter-related conditions for which treatment options have expanded substantially, yet direct real-world comparisons of modern pharmacological and surgical interventions remain scarce. We aimed to compare 1-year weight loss, glycaemic outcomes, and selected safety outcomes associated with semaglutide, tirzepatide,…

PV 검토 포인트

누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.

PubMed에서 원문 정보 보기